Sánchez-Arribas, N.; MartÃnez-Negro, M.; Villar, E.M.; Pérez, L.; OsÃo Barcina, J.; Aicart, E.; Taboada, P.; Guerrero-MartÃnez, A.; Junquera, E.
Protein Expression Knockdown in Cancer Cells Induced by a Gemini Cationic Lipid Nanovector with Histidine-Based Polar Heads. Pharmaceutics 2020, 12, 791.
https://doi.org/10.3390/pharmaceutics12090791
AMA Style
Sánchez-Arribas N, MartÃnez-Negro M, Villar EM, Pérez L, OsÃo Barcina J, Aicart E, Taboada P, Guerrero-MartÃnez A, Junquera E.
Protein Expression Knockdown in Cancer Cells Induced by a Gemini Cationic Lipid Nanovector with Histidine-Based Polar Heads. Pharmaceutics. 2020; 12(9):791.
https://doi.org/10.3390/pharmaceutics12090791
Chicago/Turabian Style
Sánchez-Arribas, Natalia, MarÃa MartÃnez-Negro, Eva M. Villar, Lourdes Pérez, José OsÃo Barcina, Emilio Aicart, Pablo Taboada, Andrés Guerrero-MartÃnez, and Elena Junquera.
2020. "Protein Expression Knockdown in Cancer Cells Induced by a Gemini Cationic Lipid Nanovector with Histidine-Based Polar Heads" Pharmaceutics 12, no. 9: 791.
https://doi.org/10.3390/pharmaceutics12090791
APA Style
Sánchez-Arribas, N., MartÃnez-Negro, M., Villar, E. M., Pérez, L., OsÃo Barcina, J., Aicart, E., Taboada, P., Guerrero-MartÃnez, A., & Junquera, E.
(2020). Protein Expression Knockdown in Cancer Cells Induced by a Gemini Cationic Lipid Nanovector with Histidine-Based Polar Heads. Pharmaceutics, 12(9), 791.
https://doi.org/10.3390/pharmaceutics12090791